New research and changing paradigms of coagulopathy in children after cardiac surgery: A narrative review
DOI:
https://doi.org/10.57125/FEM.2022.03.25.03Keywords:
congenital heart disease, cardiopulmonary, bypass, coagulopathy, cardiac surgeryAbstract
Background: Congenital heart disease (CHD) is a disorder and abnormality of the heart or the great vessels of the thorax, which usually occurs during fetal development. It has been reported that CHD is a common condition. Nearly 25% of newborns with critical types of CHD require surgical intervention in the first year of life. Hence, increasing numbers of the annually conducted cardiopulmonary bypass (CPB) cardiac surgeries are usually associated with postoperative bleeding and coagulopathy. Bleeding after CPB usually requires a replacement therapy, including the transfusion of whole blood, red blood cells, coagulation factors, or platelets.
Aim: to identify the pathophysiology of coagulopathy following cardiac surgery, how it impacts the clinical outcomes, and the available management options.
Methods: In this review, we only included English articles from common electronic databases such as PubMed /MEDLINE, Web of Science, Scopus, and the Cochrane Library with the keywords "congenital heart disease", "cardiac surgery" combined with keywords involving "coagulopathy" The end date for this review is February 2022.
Scientific novelty: This review aims to briefly review the problem of post-CPB bleeding in the pediatric population regarding multiple aspects. The medical literature lacks a comprehensive review regarding the problem of CHD, its prevalence, types, surgical options, post-cardiac surgery complications such as coagulopathy, the pathophysiology of the coagulopathy, and the preventive and therapeutic measures.
The practical significance of the result obtained: This review may help surgeons and pediatricians deeply understand post-CPB coagulopathy's pathophysiology and how to anticipate, prevent, and manage it properly. Antifibrinolytic pharmaceuticals represent the mainstay for managing this problem; their administration during CPB reduces the risk of postoperative bleeding. Blood component transfusion is also an alternative option.
Conclusion: Post-cardiac surgery, coagulopathy, and bleeding are major problems facing cardiothoracic surgeons. Postoperative bleeding, especially in the pediatric population, is one of the common causes of surgical re-exploration, leading to a higher risk of morbidities and mortalities. Meticulous preoperative examination, investigation, and intraoperative protective measures are important factors in avoiding and properly managing postoperative bleeding risk.
References
Desai K, Rabinowitz EJ, Epstein S. Physiologic diagnosis of congenital heart disease in cyanotic neonates. Curr Opin Pediatr [Internet]. 2019 Apr;31(2):274–83. Available from: http://journals.lww.com/00008480-201904000-00019
Mohammad Nijres B, Samuel BP, Vettukattil JJ. Subclinical atherosclerosis in patients with cyanotic congenital heart disease. Int J Cardiol [Internet]. 2019 May;282:44. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167527318359412
Jain S. Congenital heart disease: Saving lives and securing liveliness with early primary care and expert family care. J Fam Med Prim Care [Internet]. 2021;10(9):3178. Available from: https://journals.lww.com/jfmpc/Fulltext/2021/10090/Congenital_heart_disease__Saving_lives_and.4.aspx
Valleley MS, Buckley KW, Hayes KM, Fortuna RR, Geiss DM, Holt DW. Are there benefits to a fresh whole blood vs. packed red blood cell cardiopulmonary bypass prime on outcomes in neonatal and pediatric cardiac surgery? J Extra Corpor Technol [Internet]. 2007 Sep;39(3):168–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17972451
Meshram RM, Gajimwar VS. Prevalence, profile, and pattern of congenital heart disease in Central India: A prospective, observational study. Niger J Cardiol [Internet]. 2018 [cited 2023 Apr 2];15(1):45. Available from: https://www.nigjcardiol.org/article.asp?issn=0189-7969;year=2018;volume=15;issue=1;spage=45;epage=49;aulast=Meshram
Bishop JC, Blakemore K, Vricella L, Sekar P, Sagaser K, Crino J, Ness P, Kogutt BK, Boyd J, Aucott S, Jelin AC, Chiu J, Gehrie E, McMillan KN. Prenatal ABO/RHD Genotyping: A New Paradigm to Allow for Fresh Whole Blood for Cardiopulmonary Bypass in the Immediate Newborn Period. Fetal Diagn Ther [Internet]. 2018;44(2):156–9. Available from: https://www.karger.com/Article/FullText/487592
Keene SD, Patel RM, Stansfield BK, Davis J, Josephson CD, Winkler AM. Blood product transfusion and mortality in neonatal extracorporeal membrane oxygenation. Transfusion [Internet]. 2020 Feb 14;60(2):262–8. Available from: https://onlinelibrary.wiley.com/doi/10.1111/trf.15626
Raissadati A, Nieminen H, Jokinen E, Sairanen H. Progress in Late Results Among Pediatric Cardiac Surgery Patients. Circulation [Internet]. 2015 Jan 27;131(4):347–53. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.114.011190
Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing Mortality in Congenital Heart Disease. J Am Coll Cardiol [Internet]. 2010 Sep;56(14):1149–57. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109710026422
Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease. J Am Coll Cardiol [Internet]. 2008 Dec;52(23):e143–263. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109708033044
Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal Trends in Survival to Adulthood Among Patients Born With Congenital Heart Disease From 1970 to 1992 in Belgium. Circulation [Internet]. 2010 Nov 30;122(22):2264–72. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.110.946343
Yasuhara J, Garg V. Genetics of congenital heart disease: a narrative review of recent advances and clinical implications. Transl Pediatr [Internet]. 2021 Sep;10(9):2366–86. Available from: https://tp.amegroups.com/article/view/77549/html
Huml M, Fremuth J, Jehlička P. Cyanotic Heart Disease. Ces Pediatr [Internet]. 2023 Jan 31 [cited 2023 Apr 3];78(1):7–14. Available from: https://www.ncbi.nlm.nih.gov/books/NBK500001/
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart Disease and Stroke Statistics—2012 Update. Circulation [Internet]. 2012 Jan;125(1). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0b013e31823ac046
Van De Bruaene A, Meier L, Droogne W, De Meester P, Troost E, Gewillig M, Budts W. Management of acute heart failure in adult patients with congenital heart disease. Heart Fail Rev [Internet]. 2018 Jan 25;23(1):1–14. Available from: http://link.springer.com/10.1007/s10741-017-9664-x
Tulloh RMR, Medrano-Lopez C, Checchia PA, Stapper C, Sumitomo N, Gorenflo M, Jung Bae E, Juanico A, Gil-Jaurena JM, Wu MH, Farha T, Dodge-Khatami A, Tsang R, Notario G, Wegzyn C. CHD and respiratory syncytial virus: global expert exchange recommendations. Cardiol Young [Internet]. 2017 Oct 16;27(8):1504–21. Available from: https://www.cambridge.org/core/product/identifier/S1047951117000609/type/journal_article
Di Filippo S. Antibioprophylaxie de l’endocardite infectieuse dans les cardiopathies congénitales. Presse Med [Internet]. 2017 Jun;46(6):606–11. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0755498217302543
Jacobs JP, Mayer JE, Mavroudis C, O’Brien SM, Austin EH, Pasquali SK, Hill KD, He X, Overman DM, St. Louis JD, Karamlou T, Pizarro C, Hirsch-Romano JC, McDonald D, Han JM, Dokholyan RS, Tchervenkov CI, Lacour-Gayet F, Backer CL, Fraser CD, Tweddell JS, Elliott MJ, Walters H, Jonas RA, Prager RL, Shahian DM, Jacobs ML. The Society of Thoracic Surgeons Congenital Heart Surgery Database: 2016 Update on Outcomes and Quality. Ann Thorac Surg [Internet]. 2016 Mar;101(3):850–62. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0003497516000709
Hoffman JIE. The global burden of congenital heart disease : review article. Cardiovasc J Afr [Internet]. 2013 Jun 21;24(4):141–5. Available from: http://www.cvja.co.za/onlinejournal/vol24/vol24_issue4/#43/z
Ismail SR, Almazmi MM, Khokhar R, AlMadani W, Hadadi A, Hijazi O, Kabbani MS, Shaath G, Elbarbary M. Effects of protocol-based management on the post-operative outcome after systemic to pulmonary shunt. Egypt Hear J [Internet]. 2018 Dec;70(4):271–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1110260818300541
Rao PS. Management of Congenital Heart Disease: State of the Art; Part I—ACYANOTIC Heart Defects. Children [Internet]. 2019 Mar 8;6(3):42. Available from: https://www.mdpi.com/2227-9067/6/3/42
Syamasundar P. Congenital Heart Defects – A Review. In: Congenital Heart Disease - Selected Aspects [Internet]. InTech; 2012. Available from: http://www.intechopen.com/books/congenital-heart-disease-selected-aspects/congenital-heart-defects-a-review
Rao PS. Percutaneous balloon pulmonary valvuloplasty: State of the art. Catheter Cardiovasc Interv [Internet]. 2007 Apr 1;69(5):747–63. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ccd.20982
C. Agu N. Balloon Aortic Valvuloplasty. Pediatr Ther [Internet]. 2012;01(S5). Available from: https://www.omicsonline.org/balloon-aortic-valvuloplasty-2161-0665.S5-004.php?aid=9081
R Doshi A. Coarctation of Aorta-Management Options and Decision Making. Pediatr Ther [Internet]. 2012;01(S5). Available from: https://www.omicsonline.org/coarctation-of-aorta-management-options-and-decision-making-2161-0665.S5-006.php?aid=9082
Kumar TKS. Practical conduct of open heart procedures for congenital heart lesions. J Thorac Dis [Internet]. 2020 Mar;12(3):1235–59. Available from: http://jtd.amegroups.com/article/view/37145/html
Pereira KMFSM, de Assis CS, Cintra HNWL, Ferretti-Rebustini REL, Püschel VAA, Santana-Santos E, Rodrigues ARB, de Oliveira LB. Factors associated with the increased bleeding in the postoperative period of cardiac surgery: A cohort study. J Clin Nurs. 2019;
Petrou A, Tzimas P, Siminelakis S. Massive bleeding in cardiac surgery. Definitions, predictors and challenges. Hippokratia. 2016;20(3):179–86. PMID: 29097882. PMCID: PMC5654433
Elassal AA, Al-Ebrahim KE, Debis RS, Ragab ES, Faden MS, Fatani MA, et al. Re-exploration for bleeding after cardiac surgery: revaluation of urgency and factors promoting low rate. J Cardiothorac Surg [Internet]. 2021;16(1):166. Available from: http://dx.doi.org/10.1186/s13019-021-01545-4
Ranucci M, Baryshnikova E, Ciotti E, Ranucci M, Silvetti S. Hemodilution on cardiopulmonary bypass: Thromboelastography patterns and coagulation-related outcomes. J Cardiothorac Vasc Anesth [Internet]. 2017;31(5):1588–94. Available from: http://dx.doi.org/10.1053/j.jvca.2017.04.014
Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost [Internet]. 2021;19(3):617–32. Available from: http://dx.doi.org/10.1111/jth.15195
Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg [Internet]. 2002;21(2):232–44. Available from: http://dx.doi.org/10.1016/s1010-7940(01)01099-5
ten Cate JW, Poll T van der, Levi M, Cate HT, van Deventer SJH. Cytokines: Triggers of clinical thrombotic disease. Thromb Haemost [Internet]. 1997;78(01):415–9. Available from: http://dx.doi.org/10.1055/s-0038-1657562
Heissig B, Salama Y, Takahashi S, Osada T, Hattori K. The multifaceted role of plasminogen in inflammation. Cell Signal [Internet]. 2020;75(109761):109761. Available from: http://dx.doi.org/10.1016/j.cellsig.2020.109761
Yatsenko T, Skrypnyk M, Troyanovska O, Tobita M, Osada T, Takahashi S, et al. The role of the plasminogen/plasmin system in inflammation of the oral cavity. Cells [Internet]. 2023;12(3):445. Available from: http://dx.doi.org/10.3390/cells12030445
Levi M, E.Cromheecke M, Jonge E de, Prins MH, Mol BJM de, Briët E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: Meta-analysis of clinically relevant endpoints. Transfus Altern Transfus Med [Internet]. 2001;3(5):13–22. Available from: http://dx.doi.org/10.1111/j.1778-428x.2001.tb00045.x
Kuepper F, Dangas G, Mueller-Chorus A, Kulka PM, Zenz M, Wiebalck A. Fibrinolytic activity and bleeding after cardiac surgery with cardiopulmonary bypass and low-dose aprotinin therapy. Blood Coagul Fibrinolysis [Internet]. 2003;14(2):147–53. Available from: http://dx.doi.org/10.1097/00001721-200302000-00005
Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med [Internet]. 2004;30(10):1873–81. Available from: http://dx.doi.org/10.1007/s00134-004-2388-0
Saikia D, Mahanta B. Cardiovascular and respiratory physiology in children. Indian J Anaesth [Internet]. 2019;63(9):690–7. Available from: http://dx.doi.org/10.4103/ija.IJA_490_19
Smith MM, Schroeder DR, Nelson JA, Mauermann WJ, Welsby IJ, Pochettino A, et al. Prothrombin complex concentrate vs plasma for post-cardiopulmonary bypass coagulopathy and bleeding: A randomized clinical trial: A randomized clinical trial. JAMA Surg [Internet]. 2022;157(9):757–64. Available from: http://dx.doi.org/10.1001/jamasurg.2022.2235
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
